Man Group’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Buy
+4,481
New +$1.14M ﹤0.01% 1834
2019
Q1
– Sell
-103,084
Closed -$6.46M – 1949
2018
Q4
$6.46M Buy
+103,084
New +$6.48M 0.03% 635

Other funds holding ASND

Man Group's ASND Position: Q3 2026 in Review

Man Group opened a new position in Ascendis Pharma (ASND) in Q3 2026: 4,481 shares worth $1.02M. The stake represents ﹤0.01% of the portfolio and ranks #1834 among its holdings. This is a return to the name: Man Group previously reported a position in ASND as recently as Q4 2018.

Man Group first reported a position in ASND in Q4 2018 and has held it in 2 quarters since. The position peaked at $6.46M in Q4 2018. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Man Group held 4,481 shares of Ascendis Pharma worth $1.02M as of Q3 2026.
  • Ascendis Pharma was a new Man Group position in Q3 2026.
  • Ascendis Pharma made up ﹤0.01% of Man Group's portfolio in Q3 2026, its #1834 holding.
  • Man Group first reported a position in Ascendis Pharma in Q4 2018 and has held it in 2 quarters since.
  • Man Group's Ascendis Pharma position peaked at $6.46M in Q4 2018.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.